Relmada Therapeutics (RLMD) Change in Inventory (2012 - 2013)

Relmada Therapeutics' (RLMD) quarterly Change in Inventory came in at -$1565.0 in Q4 2013, down 184.59% year-on-year from $1850.0 in Q4 2012, and down 95.62% on a QoQ basis from -$800.0 in Q3 2013.

Relmada Therapeutics (RLMD) Change in Inventory (2012 - 2013) Analysis & Trends

Relmada Therapeutics (RLMD) has 2 years of Change in Inventory data on file, last reported at -$1565.0 in Q4 2013.

  • On a quarterly basis, Change in Inventory fell 184.59% year-over-year to -$1565.0 in Q4 2013; TTM through Nov 2013 was -$179.0, a N/A change from a year earlier, with the FY2013 full-year figure at $3236.0, up 559.06% from the prior year.
  • Change in Inventory for Q4 2013 stood at -$1565.0, down from -$800.0 in the prior quarter.
  • Over the last five years, Change in Inventory for RLMD reached as high as $1865.0 in Q1 2013 and fell as low as -$1565.0 in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 71.84 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 97.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -26.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Relmada Therapeutics 205.29 Mn 205.29 Mn - -

Historic Data

Download Data
DateValue
Nov 30, 2013 -1,565.00
Nov 30, 2013 -1,565.00
Aug 31, 2013 -800.00
Aug 31, 2013 -800.00
May 31, 2013 321.00
May 31, 2013 321.00
Feb 28, 2013 1,865.00
Feb 28, 2013 1,865.00
Nov 30, 2012 1,850.00
Nov 30, 2012 1,850.00
Aug 31, 2012 1,348.00
Aug 31, 2012 1,348.00
May 31, 2012 678.00
May 31, 2012 678.00